[Cytostatic topical therapy and prevention of recurrence in bladder papillomatosis].
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D010212:Papilloma / Q000188:drug therapy* / Q000517:prevention & control; D055502:Secondary Prevention; D013852:Thiotepa / Q000008:administration & dosage / Q000627:therapeutic use; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000517:prevention & control
D000970:Antineoplastic Agents; D013852:Thiotepa
Zytostatische Lokaltherapie und Rezidivprophylaxe der Blasenpapillomatose.